Xu; Huaqiang Eric

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xu; Huaqiang Eric.The latest application filed is for "structures and mechanism for the design of highly potent glucocorticoids".

Company Profile

3.8.16

Xu; Huaqiang Eric - Grand Rapids MI
Xu, Huaqiang Eric - Durham NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Structures and mechanism for the design of highly potent glucocorticoids Grant 10,954,265 - Xu , et al. March 23, 2	2021-03-23
Structures And Mechanism For The Design Of Highly Potent Glucocorticoids App 20190263853 - Xu; Huaqiang Eric ; et al.	2019-08-29
Highly potent glucocorticoids Grant 9,975,918 - Xu , et al. May 22, 2	2018-05-22
Highly Potent Glucocorticoids App 20160251393 - XU; Huaqiang Eric ; et al.	2016-09-01
Norrin Mutant Polypeptides, Methods of Making and Uses Thereof App 20150376252 - Xu; Huaqiang Eric ; et al.	2015-12-31
Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use Grant 8,563,513 - Xu , et al. October 22, 2	2013-10-22
ABA Receptor Agonists for Increased Plant Stress Resistance App 20130045952 - Xu; Yong ; et al.	2013-02-21
Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids Grant 8,173,670 - Xu , et al. May 8, 2	2012-05-08
Parathyroid Hormone Peptides And Parathyroid Hormone-Related Protein Peptides And Methods Of Use App 20120083448 - Xu; Huaqiang Eric ; et al.	2012-04-05
Methods for Treating Autophagy-Related Disorders App 20120045459 - MacKeigan; Jeffrey Paul ; et al.	2012-02-23
Methods Of Using Substituted Isoxazolo Pyridinones As Dissociated Glucocorticoids App 20110251211 - Xu; Huaqiang Eric ; et al.	2011-10-13
Compositions Of A V-atpase Inhibitor In Combination With A Glucocorticoid Receptor Ligand And Methods Of Use App 20110237497 - XU; HUAQIANG ERIC ; et al.	2011-09-29
Methods Of Using Substituted Isoxazolo Pyridinones As Dissociated Glucocorticoids App 20100179167 - Xu; Huaqiang Eric ; et al.	2010-07-15
Nk1-based Polypeptides And Related Methods App 20090215686 - Xu; Huaqiang Eric ; et al.	2009-08-27
Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same Grant 7,238,778 - Apolito , et al. July 3, 2	2007-07-03
Ligands for mineralocorticoid receptor (MR) and methods for screening for or designing MR ligands App 20070111265 - Xu; Huaqiang Eric ; et al.	2007-05-17
Ligands for orphan nuclear hormone receptor steroidogenic factor-1 (SF-1) App 20070026059 - Xu; Huaqiang Eric ; et al.	2007-02-01
Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same App 20050181362 - Apolito, Christopher J. ; et al.	2005-08-18
CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME App 20040137518 - Lambert, Millard Hurst III ; et al.	2004-07-15
Activator of PPAR delta Grant 6,723,740 - Chao , et al. April 20, 2	2004-04-20
Activators of PPAR delta Grant 6,710,063 - Chao , et al. March 23, 2	2004-03-23
Activator of PPAR delta App 20030203947 - Chao, Esther Yu-Hsuan ; et al.	2003-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.